Oliver Civelli

Title: Oliver Civelli: Innovator in Dopamine Receptor Research

Introduction

Oliver Civelli is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of neuroscience, particularly in the study of dopamine receptors. His work has implications for understanding various neurological conditions and developing new therapeutic strategies.

Latest Patents

Civelli holds a patent related to dopamine receptors and genes. This patent describes the cloning of a mammalian dopamine receptor gene. It provides DNA sequences encoding all or part of the dopamine receptor, along with corresponding polypeptide sequences. The methods for producing these sequences, both synthetically and through expression in transformed hosts, are also detailed. The structural information from this invention enables the preparation of labeled or unlabeled immunospecific species, particularly antibodies, and nucleic acid probes. Additionally, the patent outlines pharmaceutical compositions and methods for utilizing the products derived from this invention.

Career Highlights

Civelli is affiliated with Oregon Health & Science University, where he conducts his research. His work has garnered attention for its potential applications in the medical field, particularly in developing treatments for disorders related to dopamine signaling.

Collaborations

Civelli has collaborated with notable colleagues, including James R. Bunzow and David K. Grandy. These partnerships have contributed to advancing research in dopamine receptor biology and its implications for health.

Conclusion

Oliver Civelli's innovative work in dopamine receptor research exemplifies the impact of scientific inquiry on understanding complex biological systems. His contributions continue to pave the way for advancements in neuroscience and therapeutic development.